CG Mitter et al. declared plasma levels of D-dimer and thrombin-antithrombin-III complex (TAT), reflecting the activation of thrombin, are significantly increased in patients with breast cancer, as compared to healthy controls. This evidence concerns the gene SERPINC1 and breast cancer.